| 1 |
Ji J, Xu H, Li C, Luo J. Small-Caliber Tissue Engineered Vascular Grafts based on Human iPS Cells: Progress and Challenges. Tissue Eng Part B Rev 2023. [PMID: 36884294 DOI: 10.1089/ten.TEB.2023.0005] [Reference Citation Analysis]
|
| 2 |
Jacob C, Kitagawa A, Signoretti C, Dzieciatkowska M, D'Alessandro A, Gupte A, Hossain S, D'Addario CA, Gupte R, Gupte SA. Mediterranean G6PD variant mitigates expression of DNA methyltransferases and right heart pressure in experimental model of pulmonary hypertension. J Biol Chem 2022;298:102691. [PMID: 36372233 DOI: 10.1016/j.jbc.2022.102691] [Reference Citation Analysis]
|
| 3 |
Redel-traub G, Sampson KJ, Kass RS, Bohnen MS. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension. Biomolecules 2022;12:1341. [DOI: 10.3390/biom12101341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Liu Y, Shi JZ, Jiang R, Liu SF, He YY, van der Vorst EPC, Weber C, Döring Y, Yan Y. Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension. Front Pharmacol 2022;13:908783. [PMID: 35712711 DOI: 10.3389/fphar.2022.908783] [Reference Citation Analysis]
|
| 5 |
Lin W, Tang Y, Zhang M, Liang B, Wang M, Zha L, Yu Z. Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension. Front Med (Lausanne) 2022;9:894584. [PMID: 35646965 DOI: 10.3389/fmed.2022.894584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Colon Hidalgo D, Elajaili H, Suliman H, George MP, Delaney C, Nozik E. Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension. Antioxidants (Basel) 2022;11:428. [PMID: 35204311 DOI: 10.3390/antiox11020428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Liang S, Yegambaram M, Wang T, Wang J, Black SM, Tang H. Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension. Biomedicines 2022;10:341. [PMID: 35203550 DOI: 10.3390/biomedicines10020341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 8 |
Fois A, Dore MP, Manca A, Scano V, Pirina P, Pes GM. Association between Glucose-6-Phosphate Dehydrogenase Deficiency and Asthma. J Clin Med 2021;10:5639. [PMID: 34884340 DOI: 10.3390/jcm10235639] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Buehler PW, Swindle D, Pak DI, Fini MA, Hassell K, Nuss R, Wilkerson RB, D'Alessandro A, Irwin DC. Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features. Pulm Circ 2021;11:20458940211055996. [PMID: 34777785 DOI: 10.1177/20458940211055996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Mamazhakypov A, Hein L, Lother A. Mineralocorticoid receptors in pulmonary hypertension and right heart failure: From molecular biology to therapeutic targeting. Pharmacol Ther 2021;:107987. [PMID: 34480966 DOI: 10.1016/j.pharmthera.2021.107987] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 11 |
Garcia AA, Koperniku A, Ferreira JCB, Mochly-Rosen D. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives. Trends Pharmacol Sci 2021:S0165-6147(21)00137-1. [PMID: 34389161 DOI: 10.1016/j.tips.2021.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Anurogo D, Yuli Prasetyo Budi N, Thi Ngo MH, Huang YH, Pawitan JA. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. Int J Mol Sci 2021;22:6275. [PMID: 34200975 DOI: 10.3390/ijms22126275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Dierick F, Solinc J, Bignard J, Soubrier F, Nadaud S. Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension. Cells 2021;10:1338. [PMID: 34071347 DOI: 10.3390/cells10061338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 14 |
Kostyunina DS, McLoughlin P. Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes. Antioxidants (Basel) 2021;10:779. [PMID: 34068984 DOI: 10.3390/antiox10050779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 15 |
Dore MP, Parodi G, Portoghese M, Pes GM. The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review. Oxid Med Cell Longev 2021;2021:5529256. [PMID: 34007401 DOI: 10.1155/2021/5529256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
